Patent foramen ovale closure for patients with cryptogenic stroke: A systematic review and comprehensive meta-analysis of 5 randomized controlled trials and 14 observational studies.
CONCLUSIONS: In patients with cryptogenic stroke, PFO closure does appeared to be superior to medical therapy in stroke prevention, with an increased incidence of AF. Male, age <45 years, substantial residual shunt, and the history of ASA are the factors that will predict the benefit when PFO is closed.
PMID: 29804325 [PubMed - as supplied by publisher]
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Chen X, Chen SD, Dong Y, Dong Q Tags: CNS Neurosci Ther Source Type: research
More News: Atrial Fibrillation | Brain | Databases & Libraries | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Neuroscience | Patent Foramen Ovale | Stroke | Study